|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PPP3CA-SLC39A8 (FusionGDB2 ID:67709) |
Fusion Gene Summary for PPP3CA-SLC39A8 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PPP3CA-SLC39A8 | Fusion gene ID: 67709 | Hgene | Tgene | Gene symbol | PPP3CA | SLC39A8 | Gene ID | 5530 | 64116 |
Gene name | protein phosphatase 3 catalytic subunit alpha | solute carrier family 39 member 8 | |
Synonyms | ACCIID|CALN|CALNA|CALNA1|CCN1|CNA1|IECEE|IECEE1|PPP2B | BIGM103|CDG2N|LZT-Hs6|PP3105|ZIP8 | |
Cytomap | 4q24 | 4q24 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformCAM-PRP catalytic subunitcalcineurin A alphacalmodulin-dependent calcineurin A subunit alpha isoformprotein phosphatase 2B, catalytic subunit, alpha isoformprotein phosphatase 3 ( | zinc transporter ZIP8BCG induced integral membrane protein BIGM103BCG-induced integral membrane protein in monocyte clone 103 proteinLIV-1 subfamily of ZIP zinc transporter 6ZIP-8Zrt- and Irt-like protein 8solute carrier family 39 (metal ion transpo | |
Modification date | 20200315 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000512215, ENST00000394854, ENST00000323055, ENST00000394853, ENST00000507176, ENST00000523694, ENST00000510292, | ENST00000424970, ENST00000394833, ENST00000356736, ENST00000510255, | |
Fusion gene scores | * DoF score | 25 X 13 X 8=2600 | 6 X 6 X 3=108 |
# samples | 23 | 6 | |
** MAII score | log2(23/2600*10)=-3.49880585697144 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PPP3CA [Title/Abstract] AND SLC39A8 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PPP3CA(102014932)-SLC39A8(103184350), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PPP3CA-SLC39A8 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PPP3CA | GO:0006470 | protein dephosphorylation | 18815128|19154138 |
Hgene | PPP3CA | GO:0033173 | calcineurin-NFAT signaling cascade | 19154138|22688515 |
Hgene | PPP3CA | GO:0035690 | cellular response to drug | 11005320 |
Hgene | PPP3CA | GO:0045944 | positive regulation of transcription by RNA polymerase II | 22688515 |
Hgene | PPP3CA | GO:0051592 | response to calcium ion | 18815128 |
Tgene | SLC39A8 | GO:0006882 | cellular zinc ion homeostasis | 19401385 |
Tgene | SLC39A8 | GO:0071577 | zinc ion transmembrane transport | 19401385 |
Tgene | SLC39A8 | GO:0097080 | plasma membrane selenite transport | 27166256 |
Tgene | SLC39A8 | GO:0098711 | iron ion import across plasma membrane | 22898811 |
Fusion gene breakpoints across PPP3CA (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SLC39A8 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-56-8201-11A | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Top |
Fusion Gene ORF analysis for PPP3CA-SLC39A8 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000512215 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-3CDS | ENST00000512215 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-3CDS | ENST00000512215 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-intron | ENST00000512215 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000394854 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
In-frame | ENST00000394854 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000394854 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
5CDS-intron | ENST00000394854 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000323055 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
In-frame | ENST00000323055 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000323055 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
5CDS-intron | ENST00000323055 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000394853 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
In-frame | ENST00000394853 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000394853 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
5CDS-intron | ENST00000394853 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000507176 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
In-frame | ENST00000507176 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000507176 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
5CDS-intron | ENST00000507176 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000523694 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
In-frame | ENST00000523694 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
Frame-shift | ENST00000523694 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
5CDS-intron | ENST00000523694 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-3CDS | ENST00000510292 | ENST00000424970 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-3CDS | ENST00000510292 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-3CDS | ENST00000510292 | ENST00000356736 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
intron-intron | ENST00000510292 | ENST00000510255 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000394854 | PPP3CA | chr4 | 102014932 | - | ENST00000394833 | SLC39A8 | chr4 | 103184350 | - | 2994 | 1466 | 603 | 1478 | 291 |
ENST00000323055 | PPP3CA | chr4 | 102014932 | - | ENST00000394833 | SLC39A8 | chr4 | 103184350 | - | 2985 | 1457 | 594 | 1469 | 291 |
ENST00000394853 | PPP3CA | chr4 | 102014932 | - | ENST00000394833 | SLC39A8 | chr4 | 103184350 | - | 2841 | 1313 | 450 | 1325 | 291 |
ENST00000507176 | PPP3CA | chr4 | 102014932 | - | ENST00000394833 | SLC39A8 | chr4 | 103184350 | - | 2155 | 627 | 40 | 639 | 199 |
ENST00000523694 | PPP3CA | chr4 | 102014932 | - | ENST00000394833 | SLC39A8 | chr4 | 103184350 | - | 2109 | 581 | 0 | 593 | 197 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000394854 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - | 0.000693279 | 0.9993067 |
ENST00000323055 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - | 0.000684066 | 0.999316 |
ENST00000394853 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - | 0.000730521 | 0.9992694 |
ENST00000507176 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - | 0.001548872 | 0.9984511 |
ENST00000523694 | ENST00000394833 | PPP3CA | chr4 | 102014932 | - | SLC39A8 | chr4 | 103184350 | - | 0.000929728 | 0.99907035 |
Top |
Fusion Genomic Features for PPP3CA-SLC39A8 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PPP3CA-SLC39A8 |
Go to FGviewer for the breakpoints of chr4:102014932-chr4:103184350 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 410_429 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 451_460 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 410_429 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 451_460 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 410_429 | 411.0 | 445.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 451_460 | 411.0 | 445.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 430_450 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 430_450 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 430_450 | 411.0 | 445.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 307_311 | 260.6666666666667 | 470.0 | Motif | SAPNY motif |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 307_311 | 260.6666666666667 | 512.0 | Motif | SAPNY motif |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 307_311 | 260.6666666666667 | 522.0 | Motif | SAPNY motif |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 307_311 | 0 | 290.0 | Motif | SAPNY motif |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 341_369 | 260.6666666666667 | 470.0 | Region | Calcineurin B binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 392_406 | 260.6666666666667 | 470.0 | Region | Calmodulin-binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 407_414 | 260.6666666666667 | 470.0 | Region | Autoinhibitory segment |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 465_487 | 260.6666666666667 | 470.0 | Region | Autoinhibitory domain |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 56_340 | 260.6666666666667 | 470.0 | Region | Catalytic |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 341_369 | 260.6666666666667 | 512.0 | Region | Calcineurin B binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 392_406 | 260.6666666666667 | 512.0 | Region | Calmodulin-binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 407_414 | 260.6666666666667 | 512.0 | Region | Autoinhibitory segment |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 465_487 | 260.6666666666667 | 512.0 | Region | Autoinhibitory domain |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 56_340 | 260.6666666666667 | 512.0 | Region | Catalytic |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 341_369 | 260.6666666666667 | 522.0 | Region | Calcineurin B binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 392_406 | 260.6666666666667 | 522.0 | Region | Calmodulin-binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 407_414 | 260.6666666666667 | 522.0 | Region | Autoinhibitory segment |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 465_487 | 260.6666666666667 | 522.0 | Region | Autoinhibitory domain |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 56_340 | 260.6666666666667 | 522.0 | Region | Catalytic |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 341_369 | 0 | 290.0 | Region | Calcineurin B binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 392_406 | 0 | 290.0 | Region | Calmodulin-binding |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 407_414 | 0 | 290.0 | Region | Autoinhibitory segment |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 465_487 | 0 | 290.0 | Region | Autoinhibitory domain |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 56_340 | 0 | 290.0 | Region | Catalytic |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 343_348 | 411.0 | 461.0 | Motif | XEXPHE-motif | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 343_348 | 411.0 | 461.0 | Motif | XEXPHE-motif | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 343_348 | 411.0 | 445.0 | Motif | XEXPHE-motif | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 154_160 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 182_191 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 213_365 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 23_132 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 387_388 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 154_160 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 182_191 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 213_365 | 411.0 | 461.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 23_132 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 387_388 | 411.0 | 461.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 154_160 | 411.0 | 445.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 182_191 | 411.0 | 445.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 213_365 | 411.0 | 445.0 | Topological domain | Cytoplasmic | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 23_132 | 411.0 | 445.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 387_388 | 411.0 | 445.0 | Topological domain | Extracellular | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 133_153 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 161_181 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 192_212 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 366_386 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000356736 | 7 | 9 | 389_409 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 133_153 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 161_181 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 192_212 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 366_386 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000394833 | 6 | 8 | 389_409 | 411.0 | 461.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 133_153 | 411.0 | 445.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 161_181 | 411.0 | 445.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 192_212 | 411.0 | 445.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 366_386 | 411.0 | 445.0 | Transmembrane | Helical | |
Tgene | SLC39A8 | chr4:102014932 | chr4:103184350 | ENST00000424970 | 7 | 11 | 389_409 | 411.0 | 445.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for PPP3CA-SLC39A8 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000394854_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(transcript)=2994nt_BP=1466nt GGTGAGTGGAGGAGCGGCGCGGGGAGGCAGAGGCGAGCGCGGGCGATCGCGGCGGCGGGACGTCTCCGGCGGCCGCGGCACCAGCGGCGG CGCTCTGTGTGGAGAAGCAGGGGCAGCGGCAGCAGCAACAGCGGCAGCGGCAGCAGCAGCGGCAGCAGCGGCGGCCGCCTCTCCGCCGCC GGGGACGCCAAGGTGCGGCTGGTGGCACTGACATCGGCGGCCCTGCCTCTCCTCCCTCGCCCCCGGCCTTCCCCATGTGATCGGTCTTAA TCCTGGCCGTGTGTGCGCGCGTGGGGCTCCATTCCGCGGTGCTGGGTCTCCGTGCCGGGGTGGGTGCTCGTGTGTGCGCTTCTCCTCCCC ATCCCCCTTCCCCCAAGAATAAAAGAAGAACCGGGAGGCGTGCTCAGAAAATAAATAAATAACCACCACACACGCGCAGCCCGGAGCGAG TCGGCGGGGCTGGCGGCAGCGGCGGAGGAGGAGTGAAGGCGGCGGCGGCGGAGGAGGGACGCGCGGAAAAGGCAGCAACTTTAAAGCCAG CTCAGAGCCTAGACCTCCAGCCGAGCGGTTTGCAGCGCGGCGGCGGCGGCGGCGGCGGCGGCGTTGAGTGTCTGGCCCGCCGGTCCGGTC GGGGTGTGCAGTCGGACGGACGAGCAGCGCGTCGCTGTCCTCCGGCAGCTGGAGATGTCCGAGCCCAAGGCAATTGATCCCAAGTTGTCG ACGACCGACAGGGTGGTGAAAGCTGTTCCATTTCCTCCAAGTCACCGGCTTACAGCAAAAGAAGTGTTTGATAATGATGGAAAACCTCGT GTGGATATCTTAAAGGCGCATCTTATGAAGGAGGGAAGGCTGGAAGAGAGTGTTGCATTGAGAATAATAACAGAGGGTGCATCAATTCTT CGACAGGAAAAAAATTTGCTGGATATTGATGCGCCAGTCACTGTTTGTGGGGACATTCATGGACAATTCTTTGATTTGATGAAGCTCTTT GAAGTCGGGGGATCTCCTGCCAACACTCGCTACCTCTTCTTAGGGGACTATGTTGACAGAGGGTACTTCAGTATTGAATGTGTGCTGTAT TTGTGGGCCTTGAAAATTCTCTACCCCAAAACACTGTTTTTACTTCGTGGAAATCATGAATGTAGACATCTAACAGAGTATTTCACATTT AAACAAGAATGTAAAATAAAGTATTCAGAACGCGTATATGATGCCTGTATGGATGCCTTTGACTGCCTTCCCCTGGCTGCCCTGATGAAC CAACAGTTCCTGTGTGTGCATGGTGGTTTGTCTCCAGAGATTAACACTTTAGATGATATCAGAAAATTAGACCGATTCAAAGAACCACCT GCATATGGACCTATGTGTGATATCCTGTGGTCAGACCCCCTGGAAGATTTTGGAAATGAGAAGACTCAGGAACATTTCACTCACAACACA GTCAGGGGGTGTTCATACTTCTACAGTTTCCAGAGATGAATGATATGCTGAGAGAAAAGGTAACTGGAAGAAAAACCGATTTCACCTTCT TCATGATTCAGAATGCTGGAATGTTAACTGGATTCACAGCCATTCTACTCATTACCTTGTATGCAGGAGAAATCGAATTGGAGTAATAGA AAATGGAAGATGGTGTTGTTAATAAAGGCATTTAATAGATAAAAACATCTCCAAAAAGGATTTTGAAGCTGATCCTATTTAGTTAAAAAG ATAATTTTGCTTTCAACTGTAGGTCCAGAAAACTAATTATTGGCATCAGTCTGTGAAATAGTCCATTATTTGTTGTTAAAAATGCTTCAA AAGGTTTTCAGTGTCAGTCTGAGATGCCTGGTATATAGGAGCCTTTGGGAAATACCTATTTTTCAGTATTCCATGCATATTAGATATCAC CATGAAGCAAGAGACATGCATTCTATAATCATGTAGACACTCAGACTCAGGGGAAAATACAAGTTATATCCTGAAAGCCTTTAAAACTCT ATGGTAGGATCAAAGATTCAAATGGTTTCAGAGAGGTTTTATTTCAATTAATTTGTTCTAGTGCTTTCAAGAGCAAGTACATCAAAATGT AGAAGGTAAAATGTATGCAACACTAATATAAATTATTCCAAGTCTTTAAGGAGCCAAAGAAAAAAAAGATTTCTCACAGCTTTTTGTTCT GTTTTGTATTTCAATTAGGAACTTGCAGTATTATTTTGAAAACCATTCTAAAATAATAGGAGTTAGGAAATAAATAAAGTTTTGCTAGCC CTGCTAAGTTCAGGCTTAGAGGCTTATCGCTAAGTATAAACTTCACCAGATTCCACGAAAAGCTGGATAGCTTTTTTTCTGACTTATGTT GTGGTTGCACCCCTCACAAATGGCAGAACAGTATGTAAAGCTGGTAACACCTCGGTTTCAGTGCACCATGTGTTTGCTTTGTGAAGGTGA AGAATATGTTGGTTTAGAGAAAGAAATTGGATGTAATTTTATGCAATTTACTTTTAAAGACAAACATAACTATTTAGCAGAGAATATTTT AATAAATGCAAAACAACAGCTGGACTGCTGTACATCAAGGACAGATTAACTGGAAAACATATGTTCCTTATGTGTGATCGAGAGCCATTC AGAAAAGACTTCCTTTGTGTTCAGCCTATACTTTTCCATATGGTATACCTTGAAAAAAATTAGCACACCATGGTTATTTTTCTACCTTTT ATAAAAGACAGAGCCTGTTTACTCATTTAGAAGATAGAGAAAATTGGTCTAAAATTGAACATCCTAGATTCACACTCCCAAGTCACTTAA GGTGATTTGATGGTGAGGAAAATGATTGACAAAGCCCAACAATGATCTCAGGAATTACATTTTCCAACAGACCAAAAAATGTTTTCATGT AGCAGCAATGCAGATTTGGTGAATATTTAATATATATTTTAGTATGTATTTCACTTTATGACTGACAATTAAAAAATATTGTTTGGCCAA >In-frame_ENST00000394854_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(amino acids)=291AA_start in transcript=603_stop in transcript=1478 MSVWPAGPVGVCSRTDEQRVAVLRQLEMSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALR IITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHEC RHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEK -------------------------------------------------------------- >In-frame_ENST00000323055_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(transcript)=2985nt_BP=1457nt AGGAGCGGCGCGGGGAGGCAGAGGCGAGCGCGGGCGATCGCGGCGGCGGGACGTCTCCGGCGGCCGCGGCACCAGCGGCGGCGCTCTGTG TGGAGAAGCAGGGGCAGCGGCAGCAGCAACAGCGGCAGCGGCAGCAGCAGCGGCAGCAGCGGCGGCCGCCTCTCCGCCGCCGGGGACGCC AAGGTGCGGCTGGTGGCACTGACATCGGCGGCCCTGCCTCTCCTCCCTCGCCCCCGGCCTTCCCCATGTGATCGGTCTTAATCCTGGCCG TGTGTGCGCGCGTGGGGCTCCATTCCGCGGTGCTGGGTCTCCGTGCCGGGGTGGGTGCTCGTGTGTGCGCTTCTCCTCCCCATCCCCCTT CCCCCAAGAATAAAAGAAGAACCGGGAGGCGTGCTCAGAAAATAAATAAATAACCACCACACACGCGCAGCCCGGAGCGAGTCGGCGGGG CTGGCGGCAGCGGCGGAGGAGGAGTGAAGGCGGCGGCGGCGGAGGAGGGACGCGCGGAAAAGGCAGCAACTTTAAAGCCAGCTCAGAGCC TAGACCTCCAGCCGAGCGGTTTGCAGCGCGGCGGCGGCGGCGGCGGCGGCGGCGTTGAGTGTCTGGCCCGCCGGTCCGGTCGGGGTGTGC AGTCGGACGGACGAGCAGCGCGTCGCTGTCCTCCGGCAGCTGGAGATGTCCGAGCCCAAGGCAATTGATCCCAAGTTGTCGACGACCGAC AGGGTGGTGAAAGCTGTTCCATTTCCTCCAAGTCACCGGCTTACAGCAAAAGAAGTGTTTGATAATGATGGAAAACCTCGTGTGGATATC TTAAAGGCGCATCTTATGAAGGAGGGAAGGCTGGAAGAGAGTGTTGCATTGAGAATAATAACAGAGGGTGCATCAATTCTTCGACAGGAA AAAAATTTGCTGGATATTGATGCGCCAGTCACTGTTTGTGGGGACATTCATGGACAATTCTTTGATTTGATGAAGCTCTTTGAAGTCGGG GGATCTCCTGCCAACACTCGCTACCTCTTCTTAGGGGACTATGTTGACAGAGGGTACTTCAGTATTGAATGTGTGCTGTATTTGTGGGCC TTGAAAATTCTCTACCCCAAAACACTGTTTTTACTTCGTGGAAATCATGAATGTAGACATCTAACAGAGTATTTCACATTTAAACAAGAA TGTAAAATAAAGTATTCAGAACGCGTATATGATGCCTGTATGGATGCCTTTGACTGCCTTCCCCTGGCTGCCCTGATGAACCAACAGTTC CTGTGTGTGCATGGTGGTTTGTCTCCAGAGATTAACACTTTAGATGATATCAGAAAATTAGACCGATTCAAAGAACCACCTGCATATGGA CCTATGTGTGATATCCTGTGGTCAGACCCCCTGGAAGATTTTGGAAATGAGAAGACTCAGGAACATTTCACTCACAACACAGTCAGGGGG TGTTCATACTTCTACAGTTTCCAGAGATGAATGATATGCTGAGAGAAAAGGTAACTGGAAGAAAAACCGATTTCACCTTCTTCATGATTC AGAATGCTGGAATGTTAACTGGATTCACAGCCATTCTACTCATTACCTTGTATGCAGGAGAAATCGAATTGGAGTAATAGAAAATGGAAG ATGGTGTTGTTAATAAAGGCATTTAATAGATAAAAACATCTCCAAAAAGGATTTTGAAGCTGATCCTATTTAGTTAAAAAGATAATTTTG CTTTCAACTGTAGGTCCAGAAAACTAATTATTGGCATCAGTCTGTGAAATAGTCCATTATTTGTTGTTAAAAATGCTTCAAAAGGTTTTC AGTGTCAGTCTGAGATGCCTGGTATATAGGAGCCTTTGGGAAATACCTATTTTTCAGTATTCCATGCATATTAGATATCACCATGAAGCA AGAGACATGCATTCTATAATCATGTAGACACTCAGACTCAGGGGAAAATACAAGTTATATCCTGAAAGCCTTTAAAACTCTATGGTAGGA TCAAAGATTCAAATGGTTTCAGAGAGGTTTTATTTCAATTAATTTGTTCTAGTGCTTTCAAGAGCAAGTACATCAAAATGTAGAAGGTAA AATGTATGCAACACTAATATAAATTATTCCAAGTCTTTAAGGAGCCAAAGAAAAAAAAGATTTCTCACAGCTTTTTGTTCTGTTTTGTAT TTCAATTAGGAACTTGCAGTATTATTTTGAAAACCATTCTAAAATAATAGGAGTTAGGAAATAAATAAAGTTTTGCTAGCCCTGCTAAGT TCAGGCTTAGAGGCTTATCGCTAAGTATAAACTTCACCAGATTCCACGAAAAGCTGGATAGCTTTTTTTCTGACTTATGTTGTGGTTGCA CCCCTCACAAATGGCAGAACAGTATGTAAAGCTGGTAACACCTCGGTTTCAGTGCACCATGTGTTTGCTTTGTGAAGGTGAAGAATATGT TGGTTTAGAGAAAGAAATTGGATGTAATTTTATGCAATTTACTTTTAAAGACAAACATAACTATTTAGCAGAGAATATTTTAATAAATGC AAAACAACAGCTGGACTGCTGTACATCAAGGACAGATTAACTGGAAAACATATGTTCCTTATGTGTGATCGAGAGCCATTCAGAAAAGAC TTCCTTTGTGTTCAGCCTATACTTTTCCATATGGTATACCTTGAAAAAAATTAGCACACCATGGTTATTTTTCTACCTTTTATAAAAGAC AGAGCCTGTTTACTCATTTAGAAGATAGAGAAAATTGGTCTAAAATTGAACATCCTAGATTCACACTCCCAAGTCACTTAAGGTGATTTG ATGGTGAGGAAAATGATTGACAAAGCCCAACAATGATCTCAGGAATTACATTTTCCAACAGACCAAAAAATGTTTTCATGTAGCAGCAAT GCAGATTTGGTGAATATTTAATATATATTTTAGTATGTATTTCACTTTATGACTGACAATTAAAAAATATTGTTTGGCCAAATAGTAAAC >In-frame_ENST00000323055_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(amino acids)=291AA_start in transcript=594_stop in transcript=1469 MSVWPAGPVGVCSRTDEQRVAVLRQLEMSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALR IITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHEC RHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEK -------------------------------------------------------------- >In-frame_ENST00000394853_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(transcript)=2841nt_BP=1313nt AGCAGCGGCGGCCGCCTCTCCGCCGCCGGGGACGCCAAGGTGCGGCTGGTGGCACTGACATCGGCGGCCCTGCCTCTCCTCCCTCGCCCC CGGCCTTCCCCATGTGATCGGTCTTAATCCTGGCCGTGTGTGCGCGCGTGGGGCTCCATTCCGCGGTGCTGGGTCTCCGTGCCGGGGTGG GTGCTCGTGTGTGCGCTTCTCCTCCCCATCCCCCTTCCCCCAAGAATAAAAGAAGAACCGGGAGGCGTGCTCAGAAAATAAATAAATAAC CACCACACACGCGCAGCCCGGAGCGAGTCGGCGGGGCTGGCGGCAGCGGCGGAGGAGGAGTGAAGGCGGCGGCGGCGGAGGAGGGACGCG CGGAAAAGGCAGCAACTTTAAAGCCAGCTCAGAGCCTAGACCTCCAGCCGAGCGGTTTGCAGCGCGGCGGCGGCGGCGGCGGCGGCGGCG TTGAGTGTCTGGCCCGCCGGTCCGGTCGGGGTGTGCAGTCGGACGGACGAGCAGCGCGTCGCTGTCCTCCGGCAGCTGGAGATGTCCGAG CCCAAGGCAATTGATCCCAAGTTGTCGACGACCGACAGGGTGGTGAAAGCTGTTCCATTTCCTCCAAGTCACCGGCTTACAGCAAAAGAA GTGTTTGATAATGATGGAAAACCTCGTGTGGATATCTTAAAGGCGCATCTTATGAAGGAGGGAAGGCTGGAAGAGAGTGTTGCATTGAGA ATAATAACAGAGGGTGCATCAATTCTTCGACAGGAAAAAAATTTGCTGGATATTGATGCGCCAGTCACTGTTTGTGGGGACATTCATGGA CAATTCTTTGATTTGATGAAGCTCTTTGAAGTCGGGGGATCTCCTGCCAACACTCGCTACCTCTTCTTAGGGGACTATGTTGACAGAGGG TACTTCAGTATTGAATGTGTGCTGTATTTGTGGGCCTTGAAAATTCTCTACCCCAAAACACTGTTTTTACTTCGTGGAAATCATGAATGT AGACATCTAACAGAGTATTTCACATTTAAACAAGAATGTAAAATAAAGTATTCAGAACGCGTATATGATGCCTGTATGGATGCCTTTGAC TGCCTTCCCCTGGCTGCCCTGATGAACCAACAGTTCCTGTGTGTGCATGGTGGTTTGTCTCCAGAGATTAACACTTTAGATGATATCAGA AAATTAGACCGATTCAAAGAACCACCTGCATATGGACCTATGTGTGATATCCTGTGGTCAGACCCCCTGGAAGATTTTGGAAATGAGAAG ACTCAGGAACATTTCACTCACAACACAGTCAGGGGGTGTTCATACTTCTACAGTTTCCAGAGATGAATGATATGCTGAGAGAAAAGGTAA CTGGAAGAAAAACCGATTTCACCTTCTTCATGATTCAGAATGCTGGAATGTTAACTGGATTCACAGCCATTCTACTCATTACCTTGTATG CAGGAGAAATCGAATTGGAGTAATAGAAAATGGAAGATGGTGTTGTTAATAAAGGCATTTAATAGATAAAAACATCTCCAAAAAGGATTT TGAAGCTGATCCTATTTAGTTAAAAAGATAATTTTGCTTTCAACTGTAGGTCCAGAAAACTAATTATTGGCATCAGTCTGTGAAATAGTC CATTATTTGTTGTTAAAAATGCTTCAAAAGGTTTTCAGTGTCAGTCTGAGATGCCTGGTATATAGGAGCCTTTGGGAAATACCTATTTTT CAGTATTCCATGCATATTAGATATCACCATGAAGCAAGAGACATGCATTCTATAATCATGTAGACACTCAGACTCAGGGGAAAATACAAG TTATATCCTGAAAGCCTTTAAAACTCTATGGTAGGATCAAAGATTCAAATGGTTTCAGAGAGGTTTTATTTCAATTAATTTGTTCTAGTG CTTTCAAGAGCAAGTACATCAAAATGTAGAAGGTAAAATGTATGCAACACTAATATAAATTATTCCAAGTCTTTAAGGAGCCAAAGAAAA AAAAGATTTCTCACAGCTTTTTGTTCTGTTTTGTATTTCAATTAGGAACTTGCAGTATTATTTTGAAAACCATTCTAAAATAATAGGAGT TAGGAAATAAATAAAGTTTTGCTAGCCCTGCTAAGTTCAGGCTTAGAGGCTTATCGCTAAGTATAAACTTCACCAGATTCCACGAAAAGC TGGATAGCTTTTTTTCTGACTTATGTTGTGGTTGCACCCCTCACAAATGGCAGAACAGTATGTAAAGCTGGTAACACCTCGGTTTCAGTG CACCATGTGTTTGCTTTGTGAAGGTGAAGAATATGTTGGTTTAGAGAAAGAAATTGGATGTAATTTTATGCAATTTACTTTTAAAGACAA ACATAACTATTTAGCAGAGAATATTTTAATAAATGCAAAACAACAGCTGGACTGCTGTACATCAAGGACAGATTAACTGGAAAACATATG TTCCTTATGTGTGATCGAGAGCCATTCAGAAAAGACTTCCTTTGTGTTCAGCCTATACTTTTCCATATGGTATACCTTGAAAAAAATTAG CACACCATGGTTATTTTTCTACCTTTTATAAAAGACAGAGCCTGTTTACTCATTTAGAAGATAGAGAAAATTGGTCTAAAATTGAACATC CTAGATTCACACTCCCAAGTCACTTAAGGTGATTTGATGGTGAGGAAAATGATTGACAAAGCCCAACAATGATCTCAGGAATTACATTTT CCAACAGACCAAAAAATGTTTTCATGTAGCAGCAATGCAGATTTGGTGAATATTTAATATATATTTTAGTATGTATTTCACTTTATGACT >In-frame_ENST00000394853_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(amino acids)=291AA_start in transcript=450_stop in transcript=1325 MSVWPAGPVGVCSRTDEQRVAVLRQLEMSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALR IITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHEC RHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEK -------------------------------------------------------------- >In-frame_ENST00000507176_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(transcript)=2155nt_BP=627nt CAGTCGGACGGACGAGCAGCGCGTCGCTGTCCTCCGGCAGCTGGAGATGTCCGAGCCCAAGGCAATTGATCCCAAGTTGTCGACGACCGA CAGGGTGGTGAAAGTTTGTGGGGACATTCATGGACAATTCTTTGATTTGATGAAGCTCTTTGAAGTCGGGGGATCTCCTGCCAACACTCG CTACCTCTTCTTAGGGGACTATGTTGACAGAGGGTACTTCAGTATTGAATGTGTGCTGTATTTGTGGGCCTTGAAAATTCTCTACCCCAA AACACTGTTTTTACTTCGTGGAAATCATGAATGTAGACATCTAACAGAGTATTTCACATTTAAACAAGAATGTAAAATAAAGTATTCAGA ACGCGTATATGATGCCTGTATGGATGCCTTTGACTGCCTTCCCCTGGCTGCCCTGATGAACCAACAGTTCCTGTGTGTGCATGGTGGTTT GTCTCCAGAGATTAACACTTTAGATGATATCAGAAAATTAGACCGATTCAAAGAACCACCTGCATATGGACCTATGTGTGATATCCTGTG GTCAGACCCCCTGGAAGATTTTGGAAATGAGAAGACTCAGGAACATTTCACTCACAACACAGTCAGGGGGTGTTCATACTTCTACAGTTT CCAGAGATGAATGATATGCTGAGAGAAAAGGTAACTGGAAGAAAAACCGATTTCACCTTCTTCATGATTCAGAATGCTGGAATGTTAACT GGATTCACAGCCATTCTACTCATTACCTTGTATGCAGGAGAAATCGAATTGGAGTAATAGAAAATGGAAGATGGTGTTGTTAATAAAGGC ATTTAATAGATAAAAACATCTCCAAAAAGGATTTTGAAGCTGATCCTATTTAGTTAAAAAGATAATTTTGCTTTCAACTGTAGGTCCAGA AAACTAATTATTGGCATCAGTCTGTGAAATAGTCCATTATTTGTTGTTAAAAATGCTTCAAAAGGTTTTCAGTGTCAGTCTGAGATGCCT GGTATATAGGAGCCTTTGGGAAATACCTATTTTTCAGTATTCCATGCATATTAGATATCACCATGAAGCAAGAGACATGCATTCTATAAT CATGTAGACACTCAGACTCAGGGGAAAATACAAGTTATATCCTGAAAGCCTTTAAAACTCTATGGTAGGATCAAAGATTCAAATGGTTTC AGAGAGGTTTTATTTCAATTAATTTGTTCTAGTGCTTTCAAGAGCAAGTACATCAAAATGTAGAAGGTAAAATGTATGCAACACTAATAT AAATTATTCCAAGTCTTTAAGGAGCCAAAGAAAAAAAAGATTTCTCACAGCTTTTTGTTCTGTTTTGTATTTCAATTAGGAACTTGCAGT ATTATTTTGAAAACCATTCTAAAATAATAGGAGTTAGGAAATAAATAAAGTTTTGCTAGCCCTGCTAAGTTCAGGCTTAGAGGCTTATCG CTAAGTATAAACTTCACCAGATTCCACGAAAAGCTGGATAGCTTTTTTTCTGACTTATGTTGTGGTTGCACCCCTCACAAATGGCAGAAC AGTATGTAAAGCTGGTAACACCTCGGTTTCAGTGCACCATGTGTTTGCTTTGTGAAGGTGAAGAATATGTTGGTTTAGAGAAAGAAATTG GATGTAATTTTATGCAATTTACTTTTAAAGACAAACATAACTATTTAGCAGAGAATATTTTAATAAATGCAAAACAACAGCTGGACTGCT GTACATCAAGGACAGATTAACTGGAAAACATATGTTCCTTATGTGTGATCGAGAGCCATTCAGAAAAGACTTCCTTTGTGTTCAGCCTAT ACTTTTCCATATGGTATACCTTGAAAAAAATTAGCACACCATGGTTATTTTTCTACCTTTTATAAAAGACAGAGCCTGTTTACTCATTTA GAAGATAGAGAAAATTGGTCTAAAATTGAACATCCTAGATTCACACTCCCAAGTCACTTAAGGTGATTTGATGGTGAGGAAAATGATTGA CAAAGCCCAACAATGATCTCAGGAATTACATTTTCCAACAGACCAAAAAATGTTTTCATGTAGCAGCAATGCAGATTTGGTGAATATTTA >In-frame_ENST00000507176_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(amino acids)=199AA_start in transcript=40_stop in transcript=639 MEMSEPKAIDPKLSTTDRVVKVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHECRH LTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQ -------------------------------------------------------------- >In-frame_ENST00000523694_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(transcript)=2109nt_BP=581nt ATGTCCGAGCCCAAGGCAATTGATCCCAAGTTGTCGACGACCGACAGGGTGGTGAAAGTTTGTGGGGACATTCATGGACAATTCTTTGAT TTGATGAAGCTCTTTGAAGTCGGGGGATCTCCTGCCAACACTCGCTACCTCTTCTTAGGGGACTATGTTGACAGAGGGTACTTCAGTATT GAATGTGTGCTGTATTTGTGGGCCTTGAAAATTCTCTACCCCAAAACACTGTTTTTACTTCGTGGAAATCATGAATGTAGACATCTAACA GAGTATTTCACATTTAAACAAGAATGTAAAATAAAGTATTCAGAACGCGTATATGATGCCTGTATGGATGCCTTTGACTGCCTTCCCCTG GCTGCCCTGATGAACCAACAGTTCCTGTGTGTGCATGGTGGTTTGTCTCCAGAGATTAACACTTTAGATGATATCAGAAAATTAGACCGA TTCAAAGAACCACCTGCATATGGACCTATGTGTGATATCCTGTGGTCAGACCCCCTGGAAGATTTTGGAAATGAGAAGACTCAGGAACAT TTCACTCACAACACAGTCAGGGGGTGTTCATACTTCTACAGTTTCCAGAGATGAATGATATGCTGAGAGAAAAGGTAACTGGAAGAAAAA CCGATTTCACCTTCTTCATGATTCAGAATGCTGGAATGTTAACTGGATTCACAGCCATTCTACTCATTACCTTGTATGCAGGAGAAATCG AATTGGAGTAATAGAAAATGGAAGATGGTGTTGTTAATAAAGGCATTTAATAGATAAAAACATCTCCAAAAAGGATTTTGAAGCTGATCC TATTTAGTTAAAAAGATAATTTTGCTTTCAACTGTAGGTCCAGAAAACTAATTATTGGCATCAGTCTGTGAAATAGTCCATTATTTGTTG TTAAAAATGCTTCAAAAGGTTTTCAGTGTCAGTCTGAGATGCCTGGTATATAGGAGCCTTTGGGAAATACCTATTTTTCAGTATTCCATG CATATTAGATATCACCATGAAGCAAGAGACATGCATTCTATAATCATGTAGACACTCAGACTCAGGGGAAAATACAAGTTATATCCTGAA AGCCTTTAAAACTCTATGGTAGGATCAAAGATTCAAATGGTTTCAGAGAGGTTTTATTTCAATTAATTTGTTCTAGTGCTTTCAAGAGCA AGTACATCAAAATGTAGAAGGTAAAATGTATGCAACACTAATATAAATTATTCCAAGTCTTTAAGGAGCCAAAGAAAAAAAAGATTTCTC ACAGCTTTTTGTTCTGTTTTGTATTTCAATTAGGAACTTGCAGTATTATTTTGAAAACCATTCTAAAATAATAGGAGTTAGGAAATAAAT AAAGTTTTGCTAGCCCTGCTAAGTTCAGGCTTAGAGGCTTATCGCTAAGTATAAACTTCACCAGATTCCACGAAAAGCTGGATAGCTTTT TTTCTGACTTATGTTGTGGTTGCACCCCTCACAAATGGCAGAACAGTATGTAAAGCTGGTAACACCTCGGTTTCAGTGCACCATGTGTTT GCTTTGTGAAGGTGAAGAATATGTTGGTTTAGAGAAAGAAATTGGATGTAATTTTATGCAATTTACTTTTAAAGACAAACATAACTATTT AGCAGAGAATATTTTAATAAATGCAAAACAACAGCTGGACTGCTGTACATCAAGGACAGATTAACTGGAAAACATATGTTCCTTATGTGT GATCGAGAGCCATTCAGAAAAGACTTCCTTTGTGTTCAGCCTATACTTTTCCATATGGTATACCTTGAAAAAAATTAGCACACCATGGTT ATTTTTCTACCTTTTATAAAAGACAGAGCCTGTTTACTCATTTAGAAGATAGAGAAAATTGGTCTAAAATTGAACATCCTAGATTCACAC TCCCAAGTCACTTAAGGTGATTTGATGGTGAGGAAAATGATTGACAAAGCCCAACAATGATCTCAGGAATTACATTTTCCAACAGACCAA AAAATGTTTTCATGTAGCAGCAATGCAGATTTGGTGAATATTTAATATATATTTTAGTATGTATTTCACTTTATGACTGACAATTAAAAA >In-frame_ENST00000523694_ENST00000394833_TCGA-56-8201-11A_PPP3CA_chr4_102014932_-_SLC39A8_chr4_103184350_length(amino acids)=197AA_start in transcript=0_stop in transcript=593 MSEPKAIDPKLSTTDRVVKVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLT EYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQEH -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PPP3CA-SLC39A8 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000323055 | - | 6 | 12 | 327_336 | 260.6666666666667 | 470.0 | PxIxIF motif in substrate |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394853 | - | 6 | 13 | 327_336 | 260.6666666666667 | 512.0 | PxIxIF motif in substrate |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000394854 | - | 6 | 14 | 327_336 | 260.6666666666667 | 522.0 | PxIxIF motif in substrate |
Hgene | PPP3CA | chr4:102014932 | chr4:103184350 | ENST00000512215 | - | 1 | 8 | 327_336 | 0 | 290.0 | PxIxIF motif in substrate |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PPP3CA-SLC39A8 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PPP3CA-SLC39A8 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PPP3CA | C4540199 | EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1 | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | PPP3CA | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
Hgene | PPP3CA | C0030305 | Pancreatitis | 1 | CTD_human |
Hgene | PPP3CA | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | PPP3CA | C0039584 | Testicular Diseases | 1 | CTD_human |
Hgene | PPP3CA | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
Hgene | PPP3CA | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | PPP3CA | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | PPP3CA | C1527352 | Hepatic Form of Wilson Disease | 1 | CTD_human |
Hgene | PPP3CA | C4721610 | Carcinoma, Ovarian Epithelial | 1 | CTD_human |
Hgene | PPP3CA | C4748872 | ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT | 1 | UNIPROT |
Tgene | SLC39A8 | C4225234 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | SLC39A8 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | SLC39A8 | C0677050 | Manganese Poisoning | 1 | CTD_human |